ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
Dow Jones
39.387,76
0,85%
Euro vs US Dollar
1,07765
-0,05%
Bitcoin
62.859,21
-0,30%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Durect Corp (DRRX)

  7. Durect Corp (DRRX) News

DRRX

Durect (DRRX)

Durect Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:DRRX
DatumZeitQuelleÜberschriftSymbolFirma
07/05/202422h30PR Newswire (US)DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
30/04/202413h00PR Newswire (US)DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
27/03/202421h01PR Newswire (US)DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:DRRXDurect Corp
20/03/202421h30PR Newswire (US)DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
04/03/202417h37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
04/03/202413h00PR Newswire (US)DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and CanadaNASDAQ:DRRXDurect Corp
14/02/202422h16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DRRXDurect Corp
08/02/202400h48PR Newswire (US)DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:DRRXDurect Corp
22/12/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
01/12/202322h28Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DRRXDurect Corp
13/11/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
13/11/202322h05PR Newswire (US)DURECT Corporation Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
09/11/202322h30PR Newswire (US)DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
07/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
07/11/202322h01PR Newswire (US)DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on MortalityNASDAQ:DRRXDurect Corp
07/09/202315h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
07/09/202313h00PR Newswire (US)DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
31/08/202322h30PR Newswire (US)DURECT Corporation Announces Presentations in Upcoming Investor ConferencesNASDAQ:DRRXDurect Corp
10/08/202322h21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRRXDurect Corp
10/08/202322h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRRXDurect Corp
09/08/202322h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
09/08/202322h05PR Newswire (US)DURECT Corporation Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
03/08/202322h30PR Newswire (US)DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
21/07/202323h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
21/07/202316h38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DRRXDurect Corp
20/07/202314h00PR Newswire (US)DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:DRRXDurect Corp
23/06/202323h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
23/06/202323h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
23/06/202323h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
23/06/202323h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
 Showing the most relevant articles for your search:NASDAQ:DRRX

Kürzlich von Ihnen besucht

DBI
SDXP
SDAX
CCOM
US30
US 30
TG
432
Arbor Metals
NYSE
JPM
JP Morgan Chase
FX
EURJPY
Euro vs Yen
CCOM
SILVER
SILVER
AMEX
XLE
Energy Select Sector SPDR
TG
TUI1
Tui
TG
D7G
Nel ASA
TG
MBG
MercedesBenz
NASDAQ
TSLA
Tesla
TG
NOV
Novo Nordisk
TG
LHA
Deutsche Lufthansa
TG
ALV
Allianz
PM
XAUUSD
Gold vs US Dollar
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten